What influences Australian pharmacists' decisions to supply opioids? Results from a survey and randomised controlled factorial experiment

Documenti analoghi

• Stocking and supplying naloxone: Findings from a representative sample of community pharmacies in Victoria, Australia
  di: Nandini Karthikeyan, et al.
  Pubblicazione: (2024)
• Clinical effectiveness of pharmacist administration of long‐acting injectable buprenorphine: Findings from the EPIC‐MATOD study
  di: Elizabeth Grist, et al.
  Pubblicazione: (2024)
• A Scoping Review of the Emergence of Novel Synthetic Opioids in Australian Drug Markets: What Does This Mean for Harm Reduction Responses?
  di: Emmanuel Mammoliti, et al.
  Pubblicazione: (2025)
• Provider costs of treating opioid dependence with extended‐release buprenorphine in Australia
  di: Stella Settumba, et al.
  Pubblicazione: (2024)
• Lead Astray? The Hidden Contaminants in Australian Anabolic–Androgenic Steroid Market and Their Potential Health Impact
  di: Alison Craven, et al.
  Pubblicazione: (2025)